Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration

Details for Australian Patent Application No. 2002333757 (hide)

Owner Merckle GmbH Ascentia Pharma Inc.

Inventors Martel-Pelletier, Johanne; Pelletier, Jean-Pierre

Agent Freehills

Pub. Number AU-B-2002333757

PCT Number PCT/EP02/09658

PCT Pub. Number WO2003/020267

Priority 60/315,773 30.08.01 US; 2,356,099 30.08.01 CA

Filing date 29 August 2002

Wipo publication date 18 March 2003

Acceptance publication date 3 May 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

13 February 2003 Complete Application Filed

  Priority application(s): 60/315,773 30.08.01 US; 2,356,099 30.08.01 CA

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002333757

3 May 2007 Application Accepted

  Published as AU-B-2002333757

30 August 2007 Standard Patent Sealed

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002333758-Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin K inhibitory activity for the treatment of inflammations and other diseases

2002333756-LASER GAIN MEDIUM FOR SOLID STATE DYE LASERS